Vicore Pharma Holding AB American Depositary Shares (VCRE)

Vicore Pharma Holding AB American Depositary Shares (VCRE) is a Biotechnology company in the Healthcare sector listed on the US.

As of Oct 23, 2026: market cap $244M; returns 1 day -9.1%, 1 week +4.5%.

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company focused on developing a novel class of disease-modifying therapies known as Angiotensin II type 2 receptor agonists (ATRAGs). As of July 2026, the company's primary economic engine is centered on the clinical development of its lead candidate, buloxibutid (C21), for the treatment of Idiopathic Pulmonary Fibrosis (IPF).

Groups VCRE belongs to

VCRE financial model: income statement, cash flow and balance sheet